SI-Bone (NASDAQ: SIBN)
SI-Bone Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
SI-Bone Company Info
SI-BONE, Inc. engages in the provision of implantable devices used in the surgical treatment of the sacropelvic anatomy. It offers a proprietary minimally invasive surgical implant system, called iFuse, used to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that often causes severe lower back pain. The company was founded by Mark A. Reiley and Jeffrey W. Dunn on March 2008 and is headquartered in Santa Clara, CA.
News & Analysis
Si-bone (SIBN) Q2 Revenue Jumps 22%
Why Shares of Si-Bone Jumped Tuesday
The company reported first-quarter earnings and improved revenue guidance.
Valuation
Earnings Transcripts
SI Bone INC (SIBN) Q1 2020 Earnings Call Transcript
SIBN earnings call for the period ending March 31, 2020.
SI Bone INC (SIBN) Q4 2019 Earnings Call Transcript
SIBN earnings call for the period ending December 31, 2019.
SI Bone INC (SIBN) Q3 2019 Earnings Call Transcript
SIBN earnings call for the period ending September 30, 2019.
SI Bone INC (SIBN) Q2 2019 Earnings Call Transcript
SIBN earnings call for the period ending June 30, 2019.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.